About this trial
The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and sham BreEStim and Transcutaneous Electrical Nerve Stimulation (TENS) in management of neuropathic pain in patients after spinal cord injury (SCI).
Eligibility criteria
Qualifiers
has a history of SCI > 1 year
has a DN4 (Douleur Neuropathique en 4 Questions) score of 4 or greater
has neuropathic pain >3 months
is stable on oral pain medications at least one month
Disqualifiers
is on a mechanical ventilator
is currently having active urinary tract infection (UTI)
does not have any residual sensation in the arms
has other pain (musculoskeletal, visceral etc.), but not neuropathic, e.g., shoulder pain from wheelchair use
Trial design
Treatments tested in this trial
- Active BreEStim Treatment
- Sham BreEStim Treatment
- The TENS Treatment
Treatment groups
Sponsors and collaborators
The University of Texas Health Science Center, Houston
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator